Tranexamic Acid in Hyperpigmentation Treatment Protocol Protocols
Tranexamic Acid plays a key role in professional hyperpigmentation treatment protocol treatments. A synthetic lysine derivative that inhibits plasminogen activation and UV-induced melanogenesis, reducing melanin transfer to keratinocytes.
Role of Tranexamic Acid in Hyperpigmentation Treatment Protocol
Targeted depigmentation programme combining peels, brightening serums, and photoprotection for all types of hyperpigmentation Tranexamic Acid enhances this treatment through its targeted depigmentation properties, providing brightening support during and after the procedure.
Protocol Integration
In a typical hyperpigmentation treatment protocol protocol, tranexamic acid can be utilised at several stages:
- Pre-treatment: Skin preparation with tranexamic acid-containing products to optimise treatment outcomes
- During treatment: Active tranexamic acid delivery through the treatment modality for enhanced penetration
- Post-treatment: Recovery support using tranexamic acid formulations to accelerate healing
Clinical Benefits
Combining tranexamic acid with hyperpigmentation treatment protocol offers several advantages:
- Enhanced targeted depigmentation through professional delivery methods
- Improved treatment outcomes with medical-grade brightening support
- Reduced downtime and faster recovery when supported by tranexamic acid
Skymedic Products
Skymedic offers professional-grade tranexamic acid formulations specifically designed for integration with hyperpigmentation treatment protocol protocols. All products manufactured under ISO 13485 standards.